Recombinant PDCD1 (Nivolumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits PDCD1 (Nivolumab Biosimilar)
- PDCD1 (Nivolumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp PDCD1 (Nivolumab Biosimilar) est non-conjugé
-
Application
- ELISA
- Fonction
- Nivolumab Biosimilar - Anti-PD1 mAb
- Attributs du produit
- Antibody Type: IgG4
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Classe de qualité
- Research Grade
- Isotype
- IgG4
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- 4°C for short term, -20°C for long term
-
- Antigène
- PDCD1 (Nivolumab Biosimilar)
- Abstract
- PDCD1 (Nivolumab Biosimilar) Produits
- Synonymes
- anticorps CD279, anticorps PD-1, anticorps PD1, anticorps SLEB2, anticorps hPD-1, anticorps hPD-l, anticorps programmed cell death 1, anticorps PDCD1
- Classe de substances
- Biosimilar
- Sujet
-
Nivolumab
Nivolumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
-
Vous êtes ici:
